Skip to main content

What Boston Scientific's Quarter ended Sep 30, 2026 10-Q says: 9 signals

Boston Scientific filed its latest 10-Q with the SEC on Nov 2, 2026. It discusses acquisition announced, acquisition completed and cost reduction.

Public (BSX)Medical Equipment Manufacturing10,000+ employeesbostonscientific.comLinkedIn

Get Boston Scientific's live signals in Claude or ChatGPT, or by API

AskWhat changed at Boston Scientific this week? Use Autobound signals for bostonscientific.com.
Filed
Nov 2, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
31

Source: Autobound Signal API · 115 signals tracked for Boston Scientific · updated

10-Q · latest 10

What Boston Scientific's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 9 signals

    SEC EDGAR
  2. 10-Q

    Filed · 10 signals

    SEC EDGAR

Earlier 10-Q filings

Showing 10 of 31 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Boston Scientific earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Failed ERP upgrade causes $30M backorder in EuropeA recent ERP system implementation at a key European distribution center failed, resulting in a significant $30 million backorder. This major operational disruption creates an urgent need for system integration, supply chain optimization, and IT consulting services to resolve the issue and prevent future failures.
Aggressively investing to become the #1 market share leader in EP.With its EP business growing 63%, the company explicitly stated its aim to become the overall EP market share leader. This aggressive goal to dethrone incumbents implies heavy investment in commercial resources, R&D, and marketing to sustain momentum and win.
Acknowledges product 'gap' in CRM business, plans major tech refreshLeadership acknowledged a product 'gap' in the leadless pacemaker market is causing the Core CRM business to grow below market. They are investing in a complete platform refresh ('Denali') and a new leadless product ('EMPOWER') to regain competitiveness, signaling budget for R&D, product development, and go-to-market support.
Targeting 50 bps of annual operating margin expansionThe company has a multi-year goal to expand adjusted operating margins by approximately 50 basis points annually. This creates a strong incentive to evaluate any technology or service that can drive operational efficiency, automate processes, or reduce operating expenses.
Reports $181M in Q3 net capital expenditures to fund growth.The company spent $181 million on net capital expenditures in the quarter, part of a plan to generate $3.5 billion in free cash flow for the year. This level of CapEx supports infrastructure, facilities, and equipment needed for its rapid growth and product launches.
Investing in AI software to solve unmet clinical needsBoston Scientific is actively integrating AI into its product ecosystem, such as the 'Cortex AI algorithm,' to create differentiated value and address complex medical challenges. This focus on software and AI signals an appetite for advanced analytics, machine learning platforms, and specialized software development partnerships.

Signal API · MCP

Track Boston Scientific with the Signal API

One POST /v1/companies/enrich call with bostonscientific.com returns Boston Scientific 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bostonscientific.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Boston Scientific 10-Q

When did Boston Scientific file its latest 10-Q?
Boston Scientific filed its latest 10-Q (Quarter ended Sep 30, 2026) on Nov 2, 2026. The one before it was filed on Aug 3, 2026.
What did Boston Scientific disclose in its latest 10-Q?
From the filing dated Nov 2, 2026: Board approved 2026 Restructuring Plan with expected charges of $700M to $800M
What did Boston Scientific say on its recent earnings calls?
Q3 FY2025: Failed ERP upgrade causes $30M backorder in Europe (dated Oct 22, 2025).
Where can I read Boston Scientific's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/885725/000088572526000070/bsx-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →